Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions

J Veltman, M Stoutjesdijk, R Mann, H J Huisman, J O Barentsz, J G Blickman, C Boetes, J Veltman, M Stoutjesdijk, R Mann, H J Huisman, J O Barentsz, J G Blickman, C Boetes

Abstract

The value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in characterizing breast lesions on magnetic resonance imaging (MRI) was evaluated. Sixty-eight malignant and 34 benign lesions were included. In the scanning protocol, high temporal resolution imaging was combined with high spatial resolution imaging. The high temporal resolution images were recorded every 4.1 s during initial enhancement (fast dynamic analysis). The high spatial resolution images were recorded at a temporal resolution of 86 s (slow dynamic analysis). In the fast dynamic evaluation pharmacokinetic parameters (K(trans), V(e) and k(ep)) were evaluated. In the slow dynamic analysis, each lesion was scored according to the BI-RADS classification. Two readers evaluated all data prospectively. ROC and multivariate analysis were performed. The slow dynamic analysis resulted in an AUC of 0.85 and 0.83, respectively. The fast dynamic analysis resulted in an AUC of 0.83 in both readers. The combination of both the slow and fast dynamic analyses resulted in a significant improvement of diagnostic performance with an AUC of 0.93 and 0.90 (P = 0.02). The increased diagnostic performance found when combining both methods demonstrates the additional value of our method in further improving the diagnostic performance of breast MRI.

Figures

Fig. 1
Fig. 1
Relative enhancement versus time curves of a benign (a) and malignant (b) lesion. Note that the slope of enhancement and the level of enhancement is higher for the malignant lesion compared with the benign lesion. These fast dynamic acquisitions were analyzed as described in the Materials and methods section and resulted in the color overlays as presented in Figs. 4 and 5. The data used in this figure were respectively derived from a histopathology proven fibroadenoma and an invasive ductal carcinoma. The same lesions as presented in Figs. 4 and 5
Fig. 2
Fig. 2
Scatter plots from the extracellular volume (V) versus the transfer constant (Ktrans) for reader 1 (a) and reader 2 (b). Benign and malignant cases were clustered. Clusters were summarized with an iso-probability contour computed from the cluster mean and covariance at a squared normalized radius of 2. The continuous-line ellipsoid represents the benign subgroup, the dotted-line ellipsoid represents the malignant subgroup
Fig. 3
Fig. 3
ROC curve for reader 1 (a) and reader 2 (b) displaying the fast dynamic, slow dynamic and combined analysis. No significant differences were found between the fast and slow dynamic analysis in both readers. A significant difference was found between the slow dynamic analysis and the combined analysis for both readers (P = 0.02 for both readers). The comparison between the fast dynamic analysis and the combined analysis also resulted in a significant difference for both readers (P = 0.01 and P = 0.02). No significant differences were found between the two readers
Fig. 4
Fig. 4
a Transverse reconstruction of the high-resolution subtraction sequence of the right breast. b Time versus relative enhancement curve of the slow dynamic series. Ktrans (c) and V (d) color overlay images of the right breast, including a scalar bar, to demonstrate the parameter values. The subtraction image shows a rounded, mostly sharp delineated lesion. The time versus signal intensity curve demonstrates a type 1 curve, indicative for a benign lesions. The readers classified this lesion as benign (BI-RADS 2) or probably benign needing follow up (BI-RADS 3) based on the slow dynamic analysis. The Ktrans and V parameter color overlays demonstrate relatively low values for both parameters (see Table 2 for comparison) indicative for a benign lesion. Histopathology proved this lesion to be a fibroadenoma
Fig. 5
Fig. 5
a Transverse reconstruction of the high-resolution subtraction sequence of the right breast. b Time versus relative enhancement curve of the slow dynamic series. Ktrans (c) and V (d) color overlay images of the right breast, including a scalar bar, demonstrates the parameter values. The subtraction image shows a spiculated lesion retromammillar. The time versus signal intensity curve demonstrates a type 3 curve (wash-out) suggestive for a malignancy. Both readers classified this lesion as malignant (BI-RADS 4) based on the slow dynamic analysis. The Ktrans and V parameter color overlays demonstrate high values for both parameters (see Table 2 for comparison), indicative for a malignant lesion. Histopathology proved this lesion to be an invasive ductal carcinoma

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15761078', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15761078/'}]}
    2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1023/B:BREA.0000032921.10481.dc', 'is_inner': False, 'url': 'https://doi.org/10.1023/b:brea.0000032921.10481.dc'}, {'type': 'PubMed', 'value': '15218359', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15218359/'}]}
    2. Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86:31–37
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa031759', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa031759'}, {'type': 'PubMed', 'value': '15282350', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15282350/'}]}
    2. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1148/radiol.2381042117', 'is_inner': False, 'url': 'https://doi.org/10.1148/radiol.2381042117'}, {'type': 'PubMed', 'value': '16373758', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16373758/'}]}
    2. Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Kobrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA (2006) Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238:42–53
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.ejso.2006.06.009', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.ejso.2006.06.009'}, {'type': 'PubMed', 'value': '16920327', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16920327/'}]}
    2. Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I, Parizel P (2006) Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32:901–910
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7972823', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/7972823/'}]}
    2. Boetes C, Barentsz JO, Mus RD, Van Der Sluis RF, van Erning LJ, Hendriks JH, Holland R, Ruys SH (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 193:777–781
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8184038', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8184038/'}]}
    2. Gilles R, Guinebretiere JM, Lucidarme O, Cluzel P, Janaud G, Finet JF, Tardivon A, Masselot J, Vanel D (1994) Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191:625–631
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2648479', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/2648479/'}]}
    2. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W (1989) MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 171:95–103
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7568850', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/7568850/'}]}
    2. Hulka CA, Smith BL, Sgroi DC, Tan L, Edmister WB, Semple JP, Campbell T, Kopans DB, Brady TJ, Weisskoff RM (1995) Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 197:33–38
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2916021', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/2916021/'}]}
    2. Kaiser WA, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170:681–686
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/jmri.1880060507', 'is_inner': False, 'url': 'https://doi.org/10.1002/jmri.1880060507'}, {'type': 'PubMed', 'value': '8890012', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8890012/'}]}
    2. Kelcz F, Santyr GE, Cron GO, Mongin SJ (1996) Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 6:743–752
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10189459', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10189459/'}]}
    2. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101–110
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9051042', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9051042/'}]}
    2. Nunes LW, Schnall MD, Orel SG, Hochman MG, Langlotz CP, Reynolds CA, Torosian MH (1997) Breast MR imaging: interpretation model. Radiology 202:833–841
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0730-725X(94)92448-1', 'is_inner': False, 'url': 'https://doi.org/10.1016/0730-725x(94)92448-1'}, {'type': 'PubMed', 'value': '8057758', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8057758/'}]}
    2. Perman WH, Heiberg EM, Grunz J, Herrmann VM, Janney CG (1994) A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions. Magn Reson Imaging 12:545–551
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s003300050240', 'is_inner': False, 'url': 'https://doi.org/10.1007/s003300050240'}, {'type': 'PubMed', 'value': '9265662', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9265662/'}]}
    2. Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E (1997) Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 7:1002–1005
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/cncr.11490', 'is_inner': False, 'url': 'https://doi.org/10.1002/cncr.11490'}, {'type': 'PubMed', 'value': '12879462', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12879462/'}]}
    2. Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF, Fraker DL, Czerniecki BJ (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98:468–473
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15248080', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15248080/'}]}
    2. Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T (2004) The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14:1725–1731
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/cncr.21225', 'is_inner': False, 'url': 'https://doi.org/10.1002/cncr.21225'}, {'type': 'PubMed', 'value': '15971199', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15971199/'}]}
    2. Furman-Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H (2005) Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 104:708–718
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00004728-198603000-00005', 'is_inner': False, 'url': 'https://doi.org/10.1097/00004728-198603000-00005'}, {'type': 'PubMed', 'value': '3950145', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/3950145/'}]}
    2. Heywang SH, Hahn D, Schmidt H, Krischke I, Eiermann W, Bassermann R, Lissner J (1986) MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199–204
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1148/radiol.2363040811', 'is_inner': False, 'url': 'https://doi.org/10.1148/radiol.2363040811'}, {'type': 'PubMed', 'value': '16118161', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16118161/'}]}
    2. Kuhl CK, Schild HH, Morakkabati N (2005) Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology 236:789–800
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s003300100885', 'is_inner': False, 'url': 'https://doi.org/10.1007/s003300100885'}, {'type': 'PubMed', 'value': '11511885', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11511885/'}]}
    2. Wedegärtner U, Bick U, Wörtler K, Rummeny E, Bongartz G (2001) Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria. Eur Radiol 11:1645–1650
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00004728-200009000-00011', 'is_inner': False, 'url': 'https://doi.org/10.1097/00004728-200009000-00011'}, {'type': 'PubMed', 'value': '11045693', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11045693/'}]}
    2. Sardanelli F, Rescinito G, Giordano GD, Calabrese M, Parodi RC (2000) MR dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study. J Comput Assist Tomogr 24:724–731
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1522-2594(200012)44:6<915::AID-MRM13>3.0.CO;2-S', 'is_inner': False, 'url': 'https://doi.org/10.1002/1522-2594(200012)44:6<915::aid-mrm13>3.0.co;2-s'}, {'type': 'PubMed', 'value': '11108629', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11108629/'}]}
    2. Helbich TH, Roberts TP, Gossmann A, Wendland MF, Shames DM, Adachi M, Yang S, Huber S, Daldrup H, Brasch RC (2000) Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magn Reson Med 44:915–924
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.breast.2003.10.002', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.breast.2003.10.002'}, {'type': 'PubMed', 'value': '15019691', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15019691/'}]}
    2. Gibbs P, Liney GP, Lowry M, Kneeshaw PJ, Turnbull LW (2004) Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI. Breast 13:115–121
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8259422', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8259422/'}]}
    2. Kopans DB (1994) Mammographic follow-up to detect breast cancer recurrence after conservative treatment. Radiology 190:286
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9122382', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9122382/'}]}
    2. Kuhl CK, Bieling HB, Gieseke J, Kreft BP, Sommer T, Lutterbey G, Schild HH (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15728612', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15728612/'}]}
    2. Wiener JI, Schilling KJ, Adami C, Obuchowski NA (2005) Assessment of suspected breast cancer by MRI: a prospective clinical trial using a combined kinetic and morphologic analysis. AJR Am J Roentgenol 184:878–886
    1. American College of Radiology (2003) ACR BI-RADS: magnetic resonance imaging. In: ACR Breast imaging reporting and data System. American College of Radiology, Reston
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1148/radiol.2372041724', 'is_inner': False, 'url': 'https://doi.org/10.1148/radiol.2372041724'}, {'type': 'PubMed', 'value': '16244263', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16244263/'}]}
    2. Fütterer JJ, Engelbrecht MR, Huisman HJ, Jager GJ, Hulsbergen-van de Kaa CA, Witjes JA, Barentsz JO (2005) Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237:541–549
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1148/radiol.2412051866', 'is_inner': False, 'url': 'https://doi.org/10.1148/radiol.2412051866'}, {'type': 'PubMed', 'value': '16966484', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/16966484/'}]}
    2. Fütterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, Hulsbergen-van de Kaa CA, Witjes JA, Krabbe PF, Heerschap A, Barentsz JO (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449–458
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/jmri.1085', 'is_inner': False, 'url': 'https://doi.org/10.1002/jmri.1085'}, {'type': 'PubMed', 'value': '11276106', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/11276106/'}]}
    2. Huisman HJ, Engelbrecht MR, Barentsz JO (2001) Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13:607–614
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/mrm.1910310516', 'is_inner': False, 'url': 'https://doi.org/10.1002/mrm.1910310516'}, {'type': 'PubMed', 'value': '8015413', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/8015413/'}]}
    2. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J (1994) Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 31:567–571
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/jmri.1880080519', 'is_inner': False, 'url': 'https://doi.org/10.1002/jmri.1880080519'}, {'type': 'PubMed', 'value': '9786152', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/9786152/'}]}
    2. Kovar DA, Lewis M, Karczmar GS (1998) A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging 8:1126–1134
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S', 'is_inner': False, 'url': 'https://doi.org/10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s'}, {'type': 'PubMed', 'value': '10508281', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10508281/'}]}
    2. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(05)66646-9', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(05)66646-9'}, {'type': 'PubMed', 'value': '15910949', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15910949/'}]}
    2. Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Thompson D, Warren RM (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/(SICI)1522-2586(199912)10:6<945::AID-JMRI6>3.0.CO;2-I', 'is_inner': False, 'url': 'https://doi.org/10.1002/(sici)1522-2586(199912)10:6<945::aid-jmri6>3.0.co;2-i'}, {'type': 'PubMed', 'value': '10581507', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/10581507/'}]}
    2. Liney GP, Gibbs P, Hayes C, Leach MO, Turnbull LW (1999) Dynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semi-automated region-of-interest analysis. J Magn Reson Imaging 10:945–949
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12438042', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/12438042/'}]}
    2. Kelcz F, Furman-Haran E, Grobgeld D, Degani H (2002) Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. AJR Am J Roentgenol 179:1485–1492

Source: PubMed

3
구독하다